%0 Journal Article
%T Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment.
%A Lu IN
%A Cheung PF
%A Heming M
%A Thomas C
%A Giglio G
%A Leo M
%A Erdemir M
%A Wirth T
%A König S
%A Dambietz CA
%A Schroeter CB
%A Nelke C
%A Siveke JT
%A Ruck T
%A Klotz L
%A Haider C
%A Höftberger R
%A Kleinschnitz C
%A Wiendl H
%A Hagenacker T
%A Meyer Zu Horste G
%J Nat Commun
%V 15
%N 1
%D 2024 May 15
%M 38750052
%F 17.694
%R 10.1038/s41467-024-48195-3
%X 5q-associated spinal muscular atrophy (SMA) is a motoneuron disease caused by mutations in the survival motor neuron 1 (SMN1) gene. Adaptive immunity may contribute to SMA as described in other motoneuron diseases, yet mechanisms remain elusive. Nusinersen, an antisense treatment, enhances SMN2 expression, benefiting SMA patients. Here we have longitudinally investigated SMA and nusinersen effects on local immune responses in the cerebrospinal fluid (CSF) - a surrogate of central nervous system parenchyma. Single-cell transcriptomics (SMA: N = 9 versus Control: N = 9) reveal NK cell and CD8+ T cell expansions in untreated SMA CSF, exhibiting activation and degranulation markers. Spatial transcriptomics coupled with multiplex immunohistochemistry elucidate cytotoxicity near chromatolytic motoneurons (N = 4). Post-nusinersen treatment, CSF shows unaltered protein/transcriptional profiles. These findings underscore cytotoxicity's role in SMA pathogenesis and propose it as a therapeutic target. Our study illuminates cell-mediated cytotoxicity as shared features across motoneuron diseases, suggesting broader implications.